According to the report from famous antibody drug conjugation service supplier chempartner.com, British and American scientists recently have developed one sort of new drug which can help the immune system to inhibit the cancer growth. It has been estimated that this new drug may help to treat seven kinds of cancer. Although this drug is currently only successfully tested in mice, the scientists hope this drug could be able to extend it on human using within two years.
Effectiveness of new drugs aims at the CD47 protein on the surface of the cancer cells. The function of this protein could help to prevent cancer cells be swallowed by the body's immune macrophages. The newly developed drugs can shield CD47¡¯s function and then the immune macrophages could directly eliminate the cancer cells.
The technician from famous novel antibody drug discovery service team from www.chempartner.com said that the effect of this drug on the mice body is very good and effective. The success case includes breast cancer, intestinal cancer, prostate cancer, ovarian cancer, brain tumors, bladder tumors and liver tumors.
Researchers said that it may develop a new type for cancer curing if the clinical trials prove that the drug is indeed effective for cancer patients.
About chempartner.com
We are proud to introduce to you ChemPartner, an evolution from the pure chemistry service provider that originated 12 years ago, into the full-service LifeScience CRO with deep and extensive pharmaceutical research understanding at all levels.
No comments:
Post a Comment